12 /100
LOW RISK
Score updated Jul 13, 2026

ROIV — Roivant Sciences Ltd. Dilution Risk Tracker

Track ROIV dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ROIV — Get alerts when the score changes →

As of July 13, 2026, Roivant Sciences Ltd. (ROIV) has a DilutionWatch DilutionScore of 12/100, rated LOW dilution risk. Roivant Sciences Ltd. has a market capitalization of $21.57B, 719.27M shares outstanding, 443 institutional holders tracked. Key dilution vectors include approximately 57 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
19
💰 Cash Runway
0
📊 Float Risk
17
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ROIV.
🔔 Track ROIV — Get forecast alerts →

💹 Market Data

Market Cap$21.57B
Shares Outstanding719.27M
Float545.57M
Cash$4.29B
Debt$222.03M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 32.0% shares (2026Q1 vs prior)
443 institutional holders · 694.62M shares
#1 MORGAN STANLEY 154.51M shares
#2 FMR LLC 77.98M shares
#3 BlackRock, Inc. 44.25M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest33.21M
Days to Cover4.3
% of Float6.1%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for ROIV Shareholders

Roivant Sciences Ltd. (ROIV) has a DilutionScore of 12/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for ROIV shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for ROIV in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for ROIV alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track ROIV Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ROIV — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for ROIV
📊 ROIV FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ROIV Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.